BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A AND Treatment
80 results:

  • 1. Comparison of the effectiveness of integrative immunomodulatory treatments and conventional therapies on the survival of selected gastrointestinal cancer patients.
    Kleef R; Dank M; Herold M; Agoston EI; Lohinszky J; Martinek E; Herold Z; Szasz AM
    Sci Rep; 2023 Nov; 13(1):20360. PubMed ID: 37990076
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Diagnosis and Therapy of Anal Carcinoma].
    Radke A; Beyer J
    Praxis (Bern 1994); 2022 Feb; 110(2):89-96. PubMed ID: 35105214
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Effects of Goshajinkigan (TJ-107) for oxaliplatin-induced peripheral neurotoxicity using the functional assessment of cancer therapy/gynecologic oncology group 12-item neurotoxicity questionnaire in a Phase II, multicenter, randomized, double-blind, placebo-controlled trial.
    Aoyama T; Morita S; Kono T; Hata T; Mishima H; Sakamoto J
    J Cancer Res Ther; 2021; 17(6):1473-1478. PubMed ID: 34916380
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer.
    Chen ZH; Qi JJ; Wu QN; Lu JH; Liu ZX; Wang Y; Hu PS; Li T; Lin JF; Wu XY; Miao L; Zeng ZL; Xie D; Ju HQ; Xu RH; Wang F
    J Exp Clin Cancer Res; 2019 May; 38(1):196. PubMed ID: 31088567
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Open versus minimally invasive surgery for rectal cancer: a single-center cohort study on 237 consecutive patients.
    Quero G; Rosa F; Ricci R; Fiorillo C; Giustiniani MC; Cina C; Menghi R; Doglietto GB; Alfieri S
    Updates Surg; 2019 Sep; 71(3):493-504. PubMed ID: 30868546
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Squamous cell carcinoma of the anal canal.
    Morton M; Melnitchouk N; Bleday R
    Curr Probl Cancer; 2018 Sep; 42(5):486-492. PubMed ID: 30497849
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The effect of time from diagnosis to surgery on oncological outcomes in patients undergoing surgery for colon cancer: A systematic review.
    Hangaard Hansen C; Gögenur M; Tvilling Madsen M; Gögenur I
    Eur J Surg Oncol; 2018 Oct; 44(10):1479-1485. PubMed ID: 30251641
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mesh versus non-mesh for inguinal and femoral hernia repair.
    Lockhart K; Dunn D; Teo S; Ng JY; Dhillon M; Teo E; van Driel ML
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD011517. PubMed ID: 30209805
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer.
    Chan DLH; Segelov E; Wong RS; Smith A; Herbertson RA; Li BT; Tebbutt N; Price T; Pavlakis N
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007047. PubMed ID: 28654140
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Targeting MUC1-C inhibits the AKT-S6K1-elF4A pathway regulating TIGAR translation in colorectal cancer.
    Ahmad R; Alam M; Hasegawa M; Uchida Y; Al-Obaid O; Kharbanda S; Kufe D
    Mol Cancer; 2017 Feb; 16(1):33. PubMed ID: 28153010
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Second-line systemic therapy for metastatic colorectal cancer.
    Mocellin S; Baretta Z; Roqué I Figuls M; Solà I; Martin-Richard M; Hallum S; Bonfill Cosp X
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006875. PubMed ID: 28128439
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Co-targeting translation and proteasome rapidly kills colon cancer cells with mutant RAS/RAF via ER stress.
    Li X; Li M; Ruan H; Qiu W; Xu X; Zhang L; Yu J
    Oncotarget; 2017 Feb; 8(6):9280-9292. PubMed ID: 28030835
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Management of disappearing colorectal liver metastases.
    Kuhlmann K; van Hilst J; Fisher S; Poston G
    Eur J Surg Oncol; 2016 Dec; 42(12):1798-1805. PubMed ID: 27260846
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression-free survival in patients with advanced and/or metastatic colorectal cancer.
    Wulaningsih W; Wardhana A; Watkins J; Yoshuantari N; Repana D; Van Hemelrijck M
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008593. PubMed ID: 26869023
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Water infusion versus air insufflation for colonoscopy.
    Hafner S; Zolk K; Radaelli F; Otte J; Rabenstein T; Zolk O
    Cochrane Database Syst Rev; 2015 May; (5):CD009863. PubMed ID: 26011829
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Mechanism of thioridazine-induced apoptosis of human colorectal cancer SW480 cells].
    Liu JK; Hao YJ; Huang JW; Li X; Cai HB; Peng K
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Apr; 35(4):511-5. PubMed ID: 25907934
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Anaesthetic techniques for risk of malignant tumour recurrence.
    Cakmakkaya OS; Kolodzie K; Apfel CC; Pace NL
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008877. PubMed ID: 25379840
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. eif4f is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.
    Boussemart L; Malka-Mahieu H; Girault I; Allard D; Hemmingsson O; Tomasic G; Thomas M; Basmadjian C; Ribeiro N; Thuaud F; Mateus C; Routier E; Kamsu-Kom N; Agoussi S; Eggermont AM; Désaubry L; Robert C; Vagner S
    Nature; 2014 Sep; 513(7516):105-9. PubMed ID: 25079330
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Colon carcinoma in children and adolescents: prognostic factors and outcome-a review of 11 cases.
    Salas-Valverde S; Lizano A; Gamboa Y; Vega S; Barrantes M; Santamaría S; Zamora JB
    Pediatr Surg Int; 2009 Dec; 25(12):1073-6. PubMed ID: 19816697
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer.
    De Haas-Kock DF; Buijsen J; Pijls-Johannesma M; Lutgens L; Lammering G; van Mastrigt GA; De Ruysscher DK; Lambin P; van der Zee J
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006269. PubMed ID: 19588384
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.